WHO ICTRP trial
A prospective, randomized, double-blind, placebo-controlled, multicenter trial…
EUCTR2005-004416-78-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-004416-78-DE |
|---|---|
| Public title | A prospective, randomized, double-blind, placebo-controlled, multicenter trial with an open-label extension period to investigate the efficacy and safety of NT 201, free of complexing proteins, in the treatment of glabellar frown lines |
| Scientific title | A prospective, randomized, double-blind, placebo-controlled, multicenter trial with an open-label extension period to investigate the efficacy and safety of NT 201, free of complexing proteins, in the treatment of glabellar frown lines |
| Primary sponsor | Merz Pharmaceuticals GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Treatment of glabellar frown lines MedDRA version: 8.1 Level: LLT Classification code 10052609 Term: Glabellar frown lines |
| Interventions | Trade Name: Xeomin Product Name: Xeomin Product Code: NT 201 Pharmaceutical Form: Powder for solution for injection Current Sponsor code: NT 101 Other descriptive name: Clostridium Botulinum Neurotoxin type A (150 kD) free of complexing… |
| Registration date | Dec 7, 2006 |
| Target size | 255 |
| Secondary IDs | MRZ 60201-0520/1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: